Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies

Recruiting Observational Study
Schizophrenia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 35
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Researchers propose in this project to evaluate predictive factors of non response. It is defined by the lack of symptomatic remission at month 3, for patients presenting a first episode of psychosis. It will be performed on objective markers taken from imagery techniques. The link between evolution of these markers and clinical measures will be studied.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * men and women aged 18-35 years * member or beneficiary of a social security scheme, * for women, appropriate contraception will be mandatory, as well as a negative pregnancy test, * patients with a diagnosis of schizophrenia, schizoaffective disorder or schizophreniform disord…
Contacts

Eric FAKRA, MD PhD

(0)477127885

eric.fakra@chu-st-etienne.fr

CONTACT

Marlène BONNEFOI, Project manager

(0)477120826

marlene.bonnefoi@chu-st-etienne.fr

CONTACT